Evolution and refinements in minimally invasive esophagectomy: a narrative review Authors: Emma Jacobs, Hiran C. Fernando Published: 2026 ABSTRACT Background and ObjectiveMorbidity from traditional open esophagectomies has led to the development and growth of the minimally invasive approach. As this technique has become more widely used over the last few decades, a better understanding of its utility and its effect on patient outcomes continues to take shape. The aim of this narrative review is to discuss how minimally invasive esophagectomy (MIE) has developed as a technique, how patient outcomes have changed over time, and what progress is currently being made in the perioperative adjuncts to improve patient outcomes.MethodsA search was conducted using PubMed and Google Scholar to identify studies pertaining to the advancement of MIE. No restriction was placed on a particular time frame given the historical aspect of the review. Emphasis was placed on randomized controlled trials, prospective studies, meta-analyses and systematic reviews performed within the past 10 years for discussion regarding recent developments and updates in the field.Key Content and FindingsMIE has been key in reducing pulmonary morbidity and overall post-operative complication rates compared to open esophagectomy (OE). The development of robotic-assisted minimally invasive esophagectomy (R-MIE) shows promise in improving oncologic outcomes by attaining greater lymph node yield. However, success of these procedures is associated with a learning curve that can be a barrier to achieving these outcomes and is difficult to overcome in low-volume centers. Additional interventions that can potentially improve the results of MIE include the introduction of enhanced recovery after surgery (ERAS) programs, early nutrition, and gastric preconditioning, which have demonstrated promise in improving outcomes, such as reduced anastomotic leaks, and pulmonary complications, but warrant further randomized studies.ConclusionsMIE has proven beneficial in reducing the morbidity of esophagectomies without compromising the oncologic outcome of patients with esophageal cancer. The introduction of R-MIE offers the possibility of further improving outcomes with greater dexterity and visualization. Nonetheless, the learning curve for such a procedure is steep and is an obstacle in achieving overall favorable patient outcomes. Refinements to the minimally invasive technique are currently in development and show promising evidence in reducing the morbidity of esophagectomies. Introduction Esophageal cancer is the sixth leading cause of cancer-related death in the world, and the incidence continues to rise (1). For decades, open esophagectomy (OE) had long been the standard of care for not only malignant disease, but also benign diseases with an end-stage esophagus. Nonetheless, the morbidity and mortality of an open esophageal resection can be prohibitively high (2). After the first laparoscopic surgery was performed in 1987, there was a push to develop minimally invasive techniques in nearly every field (3). It wasn’t until 1995 when minimally invasive esophagectomy (MIE) was first described in Brazil by Depaula in a small case series of twelve patients (4). MIE continued to grow in practice as surgeons sought a better alternative to the high morbidity and mortality of OE. Here, we discuss the evidence that has led to the development of MIE, hybrid esophagectomy (HE) and robotic-assisted minimally invasive esophagectomy (R-MIE), as well as current data behind perioperative adjuncts such as anastomotic techniques, gastric preconditioning, techniques to minimize delayed gastric emptying, enhanced recovery after surgery (ERAS) protocols to help mitigate complications, and discuss further investigations that are needed within the field. We present this article in accordance with the Narrative Review reporting checklist (available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-1-0103/rc). Methods PubMed and Google Scholar were searched using the terms “minimally invasive esophagectomy”, “hybrid esophagectomy”, “robotic-assisted minimally invasive esophagectomy”, “anastomotic leak in esophagectomy”. A hand search was also performed of relevant literature to identify additional sources. No time frame was used for studies regarding the “Evolution” section due to the historical aspect of this section of the review. For the “Refinement” section, focus was placed on studies within the past 10 years with emphasis on randomized controlled trials, meta-analyses, systematic reviews and propensity-matched studies. Only articles written in English were included. Table 1 further outlines the search strategy used for this review. Table 1The search strategy summaryItemsSpecificationDate of search15 September 2025Databases searchedPubMed, Google Scholar, hand search of relevant literatureSearch terms used“minimally invasive esophagectomy”, “hybrid esophagectomy”, “robotic-assisted minimally invasive esophagectomy”, “anastomotic leak in esophagectomy”TimeframeNo timeframe for “Evolution” section: emphasis placed on articles between 2015–2026 for “Refinement” sectionInclusion criteriaRandomized control trials, meta-analyses, systematic reviews, propensity matched studies; articles written in EnglishSelection processLiterature search was conducted by E.J. Final selection of articles was conducted by all authors following consensus discussion The search strategy summary Evolution of MIE MIE Prior to the development of MIE, OE had mortality rates varying between 8% in high-volume centers to as high as 23% in very low-volume centers, and a 30-day morbidity rate of 50% (2,5). Pulmonary complications were not uncommon. Nearly one-third of patients undergoing open transhiatal esophagectomy and over half of the patients undergoing open transthoracic esophagectomy were found to have post-operative pulmonary complications (6). After the first published attempt of MIE, Swanstrom reported the first North American case series, helping to establish the technical feasibility of the procedure and suggesting a potential for decreased post-operative morbidity with applied minimally invasive techniques (7). The initial reports of MIE were based on a laparoscopic transhiatal exposure. An issue with this approach was that it could be challenging to perform a transhiatal mediastinal dissection of the esophagus in obese patients, or in those who have bulky esophageal tumors. As experience was gained, surgeons started to report MIE including both laparoscopic and video-assisted thoracoscopic surgery (VATS) components (8). A prospective trial studying 222 patients at a single, high-volume institution noted a decreased 30-day operative mortality rate of 1.4% and shorter hospital length of stay (7 days) when compared to other series studying OE (9). This study eventually led to the first, multi-center, prospective phase II trial of its kind to study MIE. Thirty-day mortality rates were around 2.1%, with a 3-year overall survival of 58.4% and patients experienced acceptable morbidity rates and oncologic outcomes (10). All surgeons who participated in this trial were credentialed for the study, having to perform at least 5 MIE procedures prior to recruiting patients. The TIME trial from Holland was the first randomized control trial to compare outcomes of patients undergoing OE vs. MIE (11). In-hospital pulmonary complications were significantly decreased in the MIE group at 12% compared to 34%. Additionally, quality of life scores relating to pain, speaking and physical function were significantly improved at 6 weeks post-operatively. This helped establish the short-term benefits of MIE without compromising the oncologic integrity of the intervention (11). Quality of life remained significantly better at 1-year follow up for MIE patients without a difference in late complications between the two groups (12). A 3-year follow-up to this trial showed similar overall and disease-free survival compared to the open arm, further upholding MIE as a viable oncological option for patients (13). However, it must be taken into account that the apparent decreased morbidity of these trials was established by surgeons at high-volume centers with significant experience in minimally invasive technique and open esophagectomies (9-11). Significant learning curve morbidity has been associated with MIE (14,15). Operative times have been reported to be notably longer than OE, and anastomotic leak rates as high as 22% during the learning period (11,15), complicating the applicability of MIE in less experienced centers. Underscoring this is an analysis of the Dutch Upper GI Cancer Audit (DUCA) for transthoracic esophagectomy (16). Following the success of the TIME trial, MIE was incorporated more widely into practice in Holland. The authors compared outcomes in patients adopting MIE within the DUCA dataset to patients in the TIME study. MIE, when compared to OE, was associated with increased complications, pulmonary complications, reoperations and longer length of stay in the DUCA dataset. These results support the need to ensure adequate training and credentialing before introducing a complex minimally invasive procedure such as esophagectomy into a center. HE Alongside the totally MIE approach, in which both the abdominal and thoracic portions are performed minimally invasively, the hybrid minimally invasive esophagectomy (HE) was developed, in which either the thoracic or abdominal portions of the case were performed by a minimally invasive technique. This approach, too, was developed in an effort to reduce the morbidity of an esophagectomy, primarily concerning pulmonary complications. The feasibility of the approach was initially established by focusing on a laparoscopic approach in combination with a thoracotomy (17-19). To evaluate the overall morbidity compared to the standard open approach, two separate randomized trials tested hybrid esophagectomies vs. open. The MIOMIE trial attempted to assess the morbidity of OE with the hybrid approach (thoracotomy with laparoscopy) (20). However, high anastomotic leak rates among both arms of patients warranted early cessation of the trial. Nonetheless, the morbidity and mortality demonstrated non-inferiority of HE to open. The MIRO trial was a multicenter, randomized control trial comparing OE versus HE, with experienced surgeons utilizing a laparoscopic abdominal phase and open right thoracotomy. This study demonstrated a significant reduction of Grade II intra-operative and post-operative complications (36%) when compared to the open technique (64%), with specific regard to pulmonary complications (21). Five-year follow up of patients showed no difference in overall survival or disease-free survival when compared to the open group (22). A meta-analysis that compared a total MIE to HE demonstrated an association with lower morbidity rates in patients that underwent MIE (23). However, when comparing HE Ivor Lewis esophagectomy to MIE Ivor Lewis esophagectomy, anastomotic leak rates were higher in the MIE subgroup, which may have been secondary to a greater learning curve associated with the entirely minimally invasive technique. That being said, no randomized control evidence was included in this meta-analysis (23). R-MIE With the development of robotic surgery and its proven adaptability in other complex, anatomically challenging procedures, it’s not surprising that this new technology was tested within the field of esophageal surgery. Its ability to provide three-dimensional optics and enhanced maneuverability with articulated instruments would appear to be beneficial in overcoming the technical limitations of MIE (24,25). Horgan et al. provided the first case report of a robotic esophagectomy using a transhiatal approach in 2003 (26). This was followed by Kernstine et al. who reported a transthoracic approach to achieve a 3-field lymphadenectomy in 2007 (27). Subsequent studies helped further the role of R-MIE, although there were notable pitfalls in prolonged operating time and a relatively increased rate of complications in early series (24,27-29). Emphasis was placed on structured learning programs and increasing surgeon experience with the hopes of improving the safety profile of the approach. The ROBOT randomized controlled trial in 2019 by van der Sluis et al. demonstrated fewer post-operative complications in patients who underwent R-MIE compared to OE with equivalent oncologic outcomes (30). All participating surgeons had performed at least 50 R-MIE cases and 50 OE cases, passing the anticipated learning curve. Total operating time averaged 349 minutes—significantly longer compared to the open approach, but notably reduced from initial R-MIE reports (24,26,28-31). In addition to reduced complication rates, long-term follow-up of these patients demonstrated effective oncologic control (31). Even with the robot’s perceived technical benefit over MIE as a surgical approach in esophagectomies, the feasibility and safety profiles between the two techniques appear to be similar. Currently, only one randomized trial from China comparing R-MIE to MIE (RAMIE trial), limited to patients with squamous cell cancer, has been undertaken (32). This study, as well as a meta-analysis, demonstrated no significant differences in overall post-operative complication rates, particularly with the rate of pulmonary complications, anastomotic leak rates, and vocal cord injury (32,33). A retrospective study using propensity score matching, where all operations were performed by the same surgeon, compared R-MIE to MIE (34). In that study, R-MIE proved superior with respect to shorter intensive care unit stay and a trend for improved lymphadenectomy. The same authors are currently undertaking a randomized trial comparing R-MIE to MIE (35). In spite of the demonstrated reproducible benefits of MIE, OE remains the standard of care in many centers. A study utilizing the National Cancer Database demonstrated that 49% of esophagectomies in the US were performed by an open approach, and 51% by MIE (36). Patients who underwent MIE were more likely to be treated in the Eastern US compared to the Midwest or South, and were more likely to be treated at an academic center. Robotic operations represented a minority of the MIE approaches. Much work still needs to be done to increase the accessibility of the minimally invasive approach with increased efforts to enhance surgeon training, and developing high volume centers of excellence. Table 2 summarizes the key findings of randomized studies that have been undertaken comparing esophagectomy approaches. Table 2Summary comparing the approach of randomized controlled trials and their outcomes for MIE, HE, R-MIETitleStudiesCenter typeComparisonNo. of participantsOutcomesTIMEBiere et al., 2012 (11); Maas et al., 2015 (12); Straatman et al., 2017 (13)Multi-centerMIE vs. OE115Lower rates of pulmonary infections 2 weeks after surgery and during hospital stay after MIE; shorter hospital-stay after MIE; better short term and 1-year QOL after MIE; less blood loss after MIE; shorter operative time in OE; similar OS and DFS at 3 years; similar post-operative local recurrence and metastasesMIROMariette et al., 2019 (21); Nuytens et al., 2021 (22)Multi-centerHE vs. OE207Lower rates of major intra- and post-operative morbidity at 30 days after HE; lower incidence of major pulmonary complications after HE; similar post-operative mortality, overall intra- and post-operative morbidity at 30 days; similar operative time and median length of hospital stay; similar OS and DFS at 3 and 5 yearsMIOMIEPaireder et al., 2018 (20)Prospective, single centerHE vs. OE26Terminated early due to high anastomotic leak rate; similar operative time; similar anastomotic leak rate; similar pulmonary complication rate; similar OS and DFS at 3 and 5 yearsROBOTvan der Sluis et al., 2019 (30)Single centerR-MIE vs. OE112Fewer overall complications after R-MIE; fewer pulmonary complications after R-MIE; fewer cardiac complications after R-MIE; less blood loss after R-MIE; less post-operative pain after R-MIE; better short-term QOL after R-MIE; longer operating time in R-MIE; similar LOS; similar anastomotic leak rate; similar oncologic outcomes at 40 monthsRAMIE trialYang et al., 2022 (32)Prospective, multicenterR-MIE vs. MIE (squamous cell cancer)358Shorter operative in R-MIE; higher rate of RLN lymph node retrieval in R-MIE; similar median lymph node yield; similar blood loss; similar overall and pulmonary complication rate; similar anastomotic leak rate; similar 30- and 90-day mortality rateDFS, disease-free survival; HE, hybrid esophagectomy; LOS, length of stay; MIE, minimally invasive esophagectomy; OE, open esophagectomy; OS, overall survival; QOL, quality of life; R-MIE, robotic-assisted minimally invasive esophagectomy; RLN, recurrent laryngeal nerve. Summary comparing the approach of randomized controlled trials and their outcomes for MIE, HE, R-MIE DFS, disease-free survival; HE, hybrid esophagectomy; LOS, length of stay; MIE, minimally invasive esophagectomy; OE, open esophagectomy; OS, overall survival; QOL, quality of life; R-MIE, robotic-assisted minimally invasive esophagectomy; RLN, recurrent laryngeal nerve. Refinements in operative care It is evident that significant work has been done over the past few decades to establish MIE as a safe, feasible and preferential option to OE. Despite this, questions still remain on how to mitigate complications of an esophagectomy that persist despite the development of minimally invasive techniques. Recent studies aiming to minimize anastomotic leak risk and pulmonary complications have evaluated strategies to further improve outcomes of esophagectomy, challenging the dogma of most surgeons. These perioperative adjuncts demonstrate promising results, but many require further investigation. Anastomotic leaks Anastomotic leaks remain one of the most morbid post-operative complications of an esophagectomy. Several factors are at play when discussing the success or failure of an esophageal anastomosis, such as tissue oxygenation and perfusion, anastomotic location, technique and surgeon experience (37). Although MIE has been shown to have significantly decreased rates of post-operative cardiopulmonary complications when compared to open, anastomotic leaks remain a vexing issue. A previous meta-analysis suggested a lower anastomotic leak rate with OE (7.6%) when compared to MIE (8.6% laparoscopic MIE and 14.6% R-MIE) (38). A learning curve is still apparent for these newer techniques and surgeon experience may have played a role in the higher anastomotic leak rates observed (38,39). As techniques are being further refined within the MIE field, the ICAN randomized trial aimed to compare anastomotic locations and their outcomes in MIE (40). Patients underwent either intrathoracic or cervical anastomosis via transthoracic MIE. Results showed that significantly fewer patients experienced anastomotic leak in the intrathoracic group (12.3% vs. 31.7%), as well as fewer severe complications, and better quality of life in regard to dysphagia and trouble talking (40). The observed lower leak rate in the intrathoracic group is consistent with previous understanding of intrathoracic vs cervical anastomotic location (37). Ischemia of the gastric conduit plays a known role in the development of anastomotic leaks. With some studies suggesting a higher rate of anastomotic leaks in MIE, ways to ameliorate this issue are still being debated (38). One approach that has been used is to perform gastric preconditioning prior to esophagectomy. The idea behind this intervention is to give the stomach time to adapt to ischemia prior to anastomotic creation during the esophagectomy performed at a later time. Laparoscopic ligation and angioembolization have both been described as different techniques in gastric preconditioning. A meta-analysis regarding gastric ischemic preconditioning analyzing studies from 1996–2018, found that gastric ischemic preconditioning may be associated with a reduced incidence of overall leak (41). This finding has been corroborated in subsequent studies as well (42,43). No difference in leak rate was found between patients who underwent laparoscopic preconditioning vs. angioembolization (41,43). Evidence has suggested that increasing the interval between preconditioning and esophagectomy may lead to reduced leak rates. However, randomized control evidence on the topic in MIE patients is still lacking. One small, randomized trial of 16 patients that analyzed the effect of ischemic conditioning in MIE patients did not find any difference in perfusion of the conduit. No analysis was done on leak rates in this study (44). Our own preference is to perform gastric preconditioning usually a week before undertaking esophagectomy, as this minimizes the risk of adhesions during the esophagectomy. We will routinely divide the left gastric artery, and short gastric vessels and, in many cases, mobilize the greater curve (surgeon dependent) during the preconditioning procedure. This operation also serves as an opportunity to re-stage the patient after neoadjuvant therapy prior to committing the patient to a resection. Anastomotic technique is a subject yet to be sufficiently explored within MIE. Handsewn and a variety of stapled techniques have been used in practice; however, most available evidence focuses on outcomes in OE (45). One randomized trial in Japan found no difference in leak rate between circular vs triangular stapled anastomosis in patients who underwent either open or MIE (46). This study, however, did not separately analyze outcomes between those who underwent open vs MIE. An international database analysis looking at five different anastomotic techniques in MIE from 2019 did demonstrate an effect on leak rate, favoring intrathoracic side-to side linear, end-to-side purse string, and cervical side-to-side linear stapled anastomosis (47). Nonetheless, the learning curve and individual experience of participating surgeons were not accounted for. Consequently, there remains a lack of robust randomized evidence that focuses on the ideal anastomotic technique in MIE. Pulmonary complications Reduction in pulmonary complications has been the principal impetus behind the initial push for MIE. MIE techniques have demonstrated a significant reduction in pulmonary complications when compared to traditional OE (13,22,30). The RAMIE trial noted no statistically significant difference of pulmonary complication rates between R-MIE and MIE (32). When comparing R-MIE and MIE on meta-analysis, lower pulmonary complications rates were noted in laparoscopic MIE (10.8%) when compared to R-MIE (17.9%), with only a statistically significant decrease in pulmonary complications noted between R-MIE and OE (38). Adjuncts, such as thoracic epidural analgesia, have been used in an attempt to decrease the rates of post-operative pulmonary morbidity. While thoracic epidural analgesia is associated with a decreased rate of post-operative pulmonary complications and a lower risk of respiratory failure, most of the available evidence is based on OE data (48,49). Both MIE and thoracic epidural analgesia have been separately associated with a decreased risk of respiratory failure (49). Our practice is to avoid an epidural in patients undergoing MIE and instead perform an intercostal nerve block in combination with patient-controlled anesthesia (PCA). This avoids the risk of hypotension with epidural, possibly leading to more intravenous fluids or vasopressors in the post-operative period, as well as allowing earlier urinary catheter removal. The benefits of a thoracic epidural were evaluated in a randomized study comparing epidural to paravertebral analgesia in patients undergoing transthoracic MIE (50). Neither technique was superior with respect to complications or length of stay, however vasopressor requirement was higher on the first post-operative day in the epidural group and urinary catheter removal was earlier in the paravertebral group. While further studies are needed to determine the most appropriate interventions to reduce pulmonary morbidity of esophagectomies, it is evident that the growing use of minimally invasive techniques has aided in reducing its incidence. Gastric emptying The problem of delayed gastric emptying after esophagectomy has remained a pervasive issue that surgeons continue to grapple with in the era of MIE. Delayed gastric emptying contributes to post operative morbidity, such as obstructive symptoms, aspiration pneumonia and decreased nutritional intake. Botox injections, pyloroplasty, pyloromyotomy, and the more recent development of gastric peroral endoscopic myotomy have been used to help alleviate these issues with varying degrees of effectiveness. Previous data has shown that pyloroplasty during esophagectomies has led to lower post-operative morbidity compared to no intervention at all (51,52). However, questions remain unanswered regarding the use and effectiveness of various pyloric drainage methods in the era of minimally invasive techniques. To help delineate the efficacy of different pyloric drainage procedures, a retrospective study from a single institution compared botox, pyloroplasty, and pyloromyotomy intervention in 475 patients, with esophagectomies performed either entirely minimally invasive or via a hybrid approach (53). Results demonstrated markedly decreased rates of delayed gastric emptying with the highest rates of bile reflux in the pyloroplasty group, while patients who underwent botox experienced a shorter length of stay and less weight loss. Nonetheless, the difference in length of stay may be explained by the MIE approach used in the majority of patients in the botox group, and the HE approaches used in the majority of patients in the pyloroplasty group, suggesting a potentially confounding factor. Although the outcomes provide insight on advantages and disadvantages of different pyloric drainage procedures, the lack of randomized evidence prevents us from making a definitive conclusion. To further determine the significance of pyloroplasty, a recent phase III adaptive randomized control trial was published, comparing pyloroplasty vs. no pyloroplasty in exclusively MIE and R-MIE cases (54). Given the adaptive design of the trial, more patients were randomized to the intervention arm due to the greater likelihood of success. Rates of pneumonia were lower and the incidence of delayed gastric emptying was significantly decreased in the pyloroplasty group, supporting prior evidence that pyloric drainage procedures help reduce post operative complications after esophagectomy (51). No significant difference in quality of life was found between the two arms. It should be emphasized that although this study suggests a benefit with pyloroplasty versus no pyloric intervention, it remains unclear whether there is benefit when compared with other interventions such as botox or pyloromyotomy. Newer techniques, such as gastric peroral endoscopic myotomy, have yet to be sufficiently studied as an option. Peri-operative management Along with intra-operative techniques, peri-operative care is an important factor in the overall outcome post-esophagectomy. Several centers have adopted ERAS programs in an effort to decrease morbidity after surgery. A consensus guidelines statement on the application of ERAS specifically to esophagectomy was published in 2018 summarizing the evidence supporting ERAS interventions (55). Suggested interventions in the esophagectomy ERAS protocol included improvements in pre-operative and post-operative nutritional status, prehabilitation, early nasogastric tube removal and use of minimally invasive operative technique. An ERAS protocol was tested by Shen et al. in a randomized setting, comparing the post-operative outcomes of ERAS+ to ERAS− patients after MIE (56). Patients who underwent ERAS demonstrated a lower rate of pulmonary complications and no difference in anastomotic leak, emphasizing the benefits of ERAS in the perioperative management of MIE. Part of this study included decreasing the time from surgery to direct oral feeding (DOF) from 7 to 5 days. The NUTRIENT II trial expanded on the topic of DOF by studying the effects of immediate post-operative DOF to NPO followed by tube feeding on post-operative day 5 (57). All patients underwent jejunostomy placement, but tube feeding through the jejunostomy tube was only used in the control group. This study found no observable difference on functional recovery or the incidence and the severity of post-operative complications, such as anastomotic leak and pneumonia. Outcomes studied over 3 and 5 years demonstrated a trend towards improved overall survival in the DOF group, but did not reach statistical significance (58). Additionally, patients in the DOF group were found to have a reduced need for home care and a faster increase in quality-of-life score (59). However, a more recent propensity matched observation study noted results conflicting with that of Nutrient II, suggesting similar overall complication rates between the two groups, but more severe complications and an increased anastomotic leak rate in the DOF group (60). The subject of DOF requires further study, as the overall outcome remains unclear (57,60,61). Another area of discussion is the use of nasogastric tube drainage (NGT) after esophagectomy. Our preference is to continue to use NGT in patients undergoing MIE. A randomized trial from Scandinavia addressed the issue of NGT use after esophagectomy (62). Patients were randomized to no NGT versus five days with NGT decompression. The study was a non-inferiority design with anastomotic leak as the primary outcome. In the intent-to-treat analysis, there was a 7% difference in anastomotic leak favoring the NGT group. In the per-protocol analysis, this difference was 11.3%, favoring the continued use of NGT decompression. While ERAS protocols offer opportunities to improve outcomes after esophagectomy, there remains a great variety in practice regarding specific peri-operative interventions. Ample opportunity for investigation lies within investigating specific peri-operative management techniques. Table 3 summarizes randomized studies addressing some of these adjuncts to esophagectomy. Table 3Summary comparing the approach of randomized controlled trials and the outcomes of peri-operative adjunctsTitleStudyCenterComparisonNo. of participantsOutcomesICANvan Workum et al., 2021 (40)Multi-centerIntrathoracic vs. cervical anastomosis in MIE245Lower overall leak rate after intrathoracic; lower rate of pleural effusions requiring drainage after intrathoracic; lower RLN palsy after intrathoracic; lower rate of severe complications after intrathoracic; shorter length of hospital-stay after intrathoracic; no difference in mortality ratesLOGICVeeramootoo et al., 2012 (44)Single centerMIE with laparoscopic ischemic conditioning vs. MIE without16No difference in perfusion of gastric conduit tipPEPMENFeenstra et al., 2025 (50)MulticenterEpidural vs. paravertebral analgesia192Higher QoR-40 scores on POD1&2 after epidural; lower pain scores after epidural; greater use of vasopressors on POD1 after epidural; earlier removal of urinary catheter after paravertebral; similar QoR-40 scores by POD3; no difference in LOS and post-operative complicationsERASShen et al., 2022 (56)Prospective, single centerERAS+ vs. ERAS− in MIE118Earlier ambulation in ERAS+; lower overall morbidity in ERAS+; lower pulmonary complications in ERAS+; similar GI complication rate; similar anastomotic leak rate; similar LOSNUTRIENT IIBerkelmans, et al., 2020 (57); Geraedts et al., 2023 (58)MulticenterDOF vs. NPO + TFs132Lower rate of chyle leaks in DOF group; significantly higher survival at 3 years after DOF; improved DFS at 5 years after DOF; no difference in functional recovery; no difference in anastomotic leak rate; no difference in pneumonia or complication rate; no significant difference in 5-year survivalHayata et al., 2017 (46)Single centerCircular vs. triangular stapling anastomosis in MIE100Similar rate of anastomotic strictures; no significant difference in leak rate; similar overall morbidityKINETICHedberg et al., 2025 (62)MulticenterNo post-operative NG tube vs. NG decompression448Lower risk of anastomotic leak after NG decompression; no difference in complication rates; no difference in short term mortality; similar LOSLuketich et al., 2026 (54)Single centerPyloroplasty vs. no pyloroplasty134Lower rates of pneumonia, anastomotic leak in pyloroplasty; lower rates of delayed gastric emptying in pyloroplasty; no difference in short term outcomes or 30-day mortality; lower 30-day readmission rates in pyloroplasty group; no difference in QOL scoresDFS, disease-free survival; DOF, direct oral feeds; ERAS, enhanced recovery after surgery; GI, gastrointestinal; LOS, length of stay; MIE, minimally invasive esophagectomy; NG, nasogastric; NPO, nil per os; POD, post-operative day; QOL, quality of life; QoR, quality of recovery; RLN, recurrent laryngeal nerve; TFs, tube feeds. Summary comparing the approach of randomized controlled trials and the outcomes of peri-operative adjuncts DFS, disease-free survival; DOF, direct oral feeds; ERAS, enhanced recovery after surgery; GI, gastrointestinal; LOS, length of stay; MIE, minimally invasive esophagectomy; NG, nasogastric; NPO, nil per os; POD, post-operative day; QOL, quality of life; QoR, quality of recovery; RLN, recurrent laryngeal nerve; TFs, tube feeds. Conclusions The development of MIE has revolutionized the field of esophageal surgery by offering improved outcomes for patients suffering from benign and malignant esophageal diseases. Nonetheless, outcomes are better when operations are performed in high-volume centers with surgeons experienced in minimally invasive techniques. As evidenced by the continued prevalence of OE, efforts to increase surgeon training and exposure to MIE are needed. Many questions remain unanswered regarding the best perioperative practices in MIE. Despite the increasing use of R-MIE and MIE, randomized evidence comparing the two approaches is needed, and may be answered when the ROBOT-2 trial is completed. Robust evidence is lacking on techniques such as gastric ischemic preconditioning and anastomotic technique. Although current studies suggest a benefit with ischemic preconditioning, no direct comparison has been made between preconditioning versus no preconditioning, or the type and timing of preconditioning in MIE. Additionally, there remains no consensus regarding the best nutritional practices in the setting of a tenuous esophageal anastomosis, with DOF remaining a controversial topic. As more surgeons seek to incorporate minimally invasive techniques into their practice, further investigations moving forward are imperative to implement best practice techniques. Supplementary The article’s supplementary files as Available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-1-0103/prf